EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients

Chiara Lucchi, Cecilia Simonini iD, Cecilia Rustichelli iD, Rossella Avallone iD, Elisabetta Zucchi, Ilaria Martinelli, Giuseppe Biagini iD, Jessica Mandrioli iD

Biomolecules · 2024

DOI: 10.3390/biom14091076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Chiara Lucchi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Neurosteroids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, University of Modena and Reggio Emilia, Fondazione Cassa di Risparmio di Modena.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Produced by the mitochondria and endoplasmic reticulum, neurosteroids such as allopregnanolone are neuroprotective molecules that influence various neuronal functions and regulate neuroinflammation. They are reduced in neurodegenerative diseases, while in the Wobbler mouse model, allopregnanolone and its precursor progesterone showed protective effects on motor neuron degeneration. This single-center case-control study included 37 patients with amyotrophic lateral sclerosis (ALS) and 28 healthy controls. Cerebrospinal fluid (CSF) neurosteroid levels were quantified using liquid chromatography–electrospray tandem mass spectrometry and compared between the two cohorts. Neurosteroid concentrations have been correlated with neuroinflammation and neurodegeneration biomarkers detected through an automated immunoassay, along with disease features and progression. Pregnenolone, progesterone, allopregnanolone, pregnanolone, and testosterone levels were significantly lower in ALS patients’ CSF compared to healthy controls. A significant inverse correlation was found between neurofilament and neurosteroid levels. Neurosteroid concentrations did not correlate with disease progression, phenotype, genotype, or survival prediction. Our study suggests the independence of the disease features and its progression, from the dysregulation of neurosteroids in ALS patients’ CSF. This neurosteroid reduction may relate to disease pathogenesis or be a consequence of disease-related processes, warranting further research. The inverse correlation between neurosteroids and neurofilament levels may indicate a failure of compensatory neuroprotective mechanisms against neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisNeurosteroidsHumansMiddle AgedMaleFemaleCase-Control StudiesAgedBiomarkersPregnanoloneAdultPregnenoloneProgesteroneTestosteroneChromatography, LiquidTandem Mass Spectrometry

Stichwörter der Autor:innen

amyotrophic lateral sclerosiscerebrospinal fluidneurosteroids

Substanzen

NeurosteroidsBiomarkersPregnanolonePregnenoloneProgesteroneTestosterone

Autor:innen und Institutionen

  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Department of Neurosciences, Azienda Ospedaliero-Universitaria di Modena, 41126 Modena, Italy.
  • Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

ORCID-Profile: Cecilia Simonini, Cecilia Rustichelli, Rossella Avallone, Giuseppe Biagini, Jessica Mandrioli

Förderung

  • Ministero della Salute
  • University of Modena and Reggio Emilia
  • Fondazione Cassa di Risparmio di Modena
  • Ministero della Salute, Ricerca Finalizzata bando 2021
  • Fondazione Cassa di Risparmio di Modena-FCRM

Zitieren

APA

Lucchi, C., Simonini, C., Rustichelli, C., Avallone, R., Zucchi, E., Martinelli, I., Biagini, G., & Mandrioli, J. (2024). Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients. Biomolecules. https://doi.org/10.3390/biom14091076

Vancouver

Lucchi C, Simonini C, Rustichelli C, Avallone R, Zucchi E, Martinelli I, et al. Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients. Biomolecules. 2024. doi:10.3390/biom14091076

BibTeX
@article{Lucchi2024,
  author = {Lucchi, Chiara and Simonini, Cecilia and Rustichelli, Cecilia and Avallone, Rossella and Zucchi, Elisabetta and Martinelli, Ilaria and Biagini, Giuseppe and Mandrioli, Jessica},
  title = {Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14091076}
}
Kostenlos starten →